Geriatric Research, Education Clinical Center (GRECC) VASLCHCS, Salt Lake City, UT, USA.
J Neuroinflammation. 2010 Apr 13;7:25. doi: 10.1186/1742-2094-7-25.
We previously found that cyclooxygenase 2 (COX-2) was expressed in dying oligodendrocytes at the onset of demyelination in the Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) model of multiple sclerosis (MS) (Carlson et al. J.Neuroimmunology 2006, 149:40). This suggests that COX-2 may contribute to death of oligodendrocytes.
The goal of this study was to examine whether COX-2 contributes to excitotoxic death of oligodendrocytes and potentially contributes to demyelination.
The potential link between COX-2 and oligodendrocyte death was approached using histopathology of MS lesions to examine whether COX-2 was expressed in dying oligodendrocytes. COX-2 inhibitors were examined for their ability to limit demyelination in the TMEV-IDD model of MS and to limit excitotoxic death of oligodendrocytes in vitro. Genetic manipulation of COX-2 expression was used to determine whether COX-2 contributes to excitotoxic death of oligodendrocytes. A transgenic mouse line was generated that overexpressed COX-2 in oligodendrocytes. Oligodendrocyte cultures derived from these transgenic mice were used to examine whether increased expression of COX-2 enhanced the vulnerability of oligodendrocytes to excitotoxic death. Oligodendrocytes derived from COX-2 knockout mice were evaluated to determine if decreased COX-2 expression promotes a greater resistance to excitotoxic death.
COX-2 was expressed in dying oligodendrocytes in MS lesions. COX-2 inhibitors limited demyelination in the TMEV-IDD model of MS and protected oligodendrocytes against excitotoxic death in vitro. COX-2 expression was increased in wild-type oligodendrocytes following treatment with Kainic acid (KA). Overexpression of COX-2 in oligodendrocytes increased the sensitivity of oligodendrocytes to KA-induced excitotoxic death eight-fold compared to wild-type. Conversely, oligodendrocytes prepared from COX-2 knockout mice showed a significant decrease in sensitivity to KA induced death.
COX-2 expression was associated with dying oligodendrocytes in MS lesions and appeared to increase excitotoxic death of oligodendrocytes in culture. An understanding of how COX-2 expression influences oligodendrocyte death leading to demyelination may have important ramifications for future treatments for MS.
我们之前发现环氧化酶 2(COX-2)在多发性硬化症(MS)的 Theiler 鼠脑炎病毒诱导脱髓鞘疾病(TMEV-IDD)模型的脱髓鞘发作时在死亡的少突胶质细胞中表达(Carlson 等人,J.Neuroimmunology 2006,149:40)。这表明 COX-2 可能导致少突胶质细胞死亡。
本研究的目的是检查 COX-2 是否导致少突胶质细胞兴奋毒性死亡,并可能导致脱髓鞘。
通过 MS 病变的组织病理学检查,研究 COX-2 与少突胶质细胞死亡之间的潜在联系,以检查 COX-2 是否在死亡的少突胶质细胞中表达。检查 COX-2 抑制剂是否能够限制 TMEV-IDD 模型中 MS 的脱髓鞘,并限制体外少突胶质细胞的兴奋毒性死亡。通过遗传操作 COX-2 的表达来确定 COX-2 是否导致少突胶质细胞兴奋毒性死亡。生成了一种过表达 COX-2 的少突胶质细胞的转基因小鼠系。使用这些转基因小鼠衍生的少突胶质细胞培养物来检查 COX-2 表达增加是否增强了少突胶质细胞对兴奋毒性死亡的易感性。评估来自 COX-2 敲除小鼠的少突胶质细胞,以确定 COX-2 表达减少是否促进对兴奋毒性死亡的更大抵抗力。
MS 病变中的死亡少突胶质细胞中表达了 COX-2。COX-2 抑制剂限制了 TMEV-IDD 模型中 MS 的脱髓鞘,并在体外保护少突胶质细胞免受兴奋毒性死亡。用海人酸(KA)处理后,野生型少突胶质细胞中的 COX-2 表达增加。与野生型相比,COX-2 在少突胶质细胞中的过表达使少突胶质细胞对 KA 诱导的兴奋毒性死亡的敏感性增加了八倍。相反,来自 COX-2 敲除小鼠的少突胶质细胞对 KA 诱导的死亡表现出明显的敏感性降低。
COX-2 的表达与 MS 病变中的死亡少突胶质细胞有关,并且似乎增加了培养物中少突胶质细胞的兴奋毒性死亡。了解 COX-2 表达如何影响少突胶质细胞死亡导致脱髓鞘,可能对 MS 的未来治疗产生重要影响。